Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,593.06 76.79 0.53%
TOPIX 1,178.44 5.07 0.43%
HANG SENG 22,760.24 64.23 0.28%

TheSubway.com Update On Dicom Imaging Systems


TheSubway.com Update On Dicom Imaging Systems

WESTON, FL -- (INTERNET WIRE) -- 03/16/00 -- TheSubway.com Update on Dicom Imaging Systems (OTCBB: DCIM) with a price target of $60 per share.

Dicom Imaging Systems, Inc. (OTC BB: DCIM)'s imagEXPLORER has just received it's first upgrade. The new D-Link feature, allows virtually all Microsoft (NASDAQ: MSFT) Windows based Dental Practice Management software to be successfully bridged with the Dicom imagEXPLORER.

D-Link is a new feature upgrade to imagEXPLORER that allows the user to quickly retrieve patient based information and data elements such as name, address, unique number etc. from virtually any Windows based patient management application. This feature allows the customer to automatically create the patient file in imagEXPLORER.

CRG feels the stock is a great buy, currently trading at around the 25.00 range. CRG is currently performing an intense public relations campaign to alert new, experienced investors of this opportunity. CRG feels that the stock could be trading around the $60 mark within the next few months.

The company also recently announced that they will receive a piece of about 400 million claims with an excess of $75 billion dollars.

We are expecting an approximate number to be released soon by the company however we feel that based on the current limited number of shares outstanding (about 7.2 million) and this recent development that this justifies out new price target on DCIM.

Remember also that DCIM has declared a 3 for 1 stock split for shareholders of record at the close of business on March 31, 2000. DCIM also plans to file for NASDAQ this April 2,000.

The NASDAQ's Largest Volume Leaders.

Applied Digital Solutions (NASDAQ: ADSX), Epimmune Inc (NASDAQ: EPMN), Smurfit-Container Cp (NASDAQ: SSCC), Sovereign Bancorp,Inc (NASDAQ: SVRN), Value America Inc (NASDAQ: VUSA), Cytotherapeutics, Inc (NASDAQ: CTII), Sunglass Hut Int'l, Inc (NASDAQ: RAYS), Bid.com Intl Inc (NASDAQ: BIDS), Aetrium, Inc (NASDAQ: ATRM), Ravisent Tech Inc (NASDAQ: RVST)

About TheSubway.com

TheSubway.com, a wholly owned online asset of Capital Research Group, Inc. was developed solely for experienced, risk tolerant investors. Subscribers to TheSubway.com receive daily market commentary reports for select companies trading on various markets. Sophisticated investors are also able to receive for free, select, rare research reports and investor kits on up and coming emerging companies while they are still not widely known.

About Capital Research Group Inc.

Through TheSubway.com, Capital Research Group (CRG) introduces fundamentally sound, undervalued companies to the investment community. Capital Research Group strives to locate companies with enormous growth potential. CRG is a full service public relations / Investor relations firm. For more information about our products or services, please contact CRG at 954-217-9555 or visit us at http://www.thesubway.com.

All material herein was prepared by Capital Research Group Inc. (CRG) based upon information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this report, have not approved the statements made in this report. This discussion contains forward-looking statements that involve risks and uncertainties. A company's actual results could differ materially from those described in any forward- looking statements or announcements discussed within. This material is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or sell the securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on www.thesubway.com. CRG has been compensated by one or more of the companies listed herein (90,000 DCIM) for the preparation and distribution of this report. Much of this report was derived from a paid report written by National Capital Securities Research. CRG, its affiliates, and/or its officers, directors and employees may buy, sell or have a position in the securities discussed in this report and may profit in the event the shares of the companies discussed in this report rise in value. For additional information visit http://www.thesubway.com or call Capital research Group Inc. direct.

Contact: Charles T. Tamburello, Capital Research Group Inc Phone: 954-217-9555 Fax: 954-389-5756 Email: chuck@TheSubway.com Provider ID: 02006633

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement